Javascript must be enabled to continue!
Modulation of AMPA Receptors in Cultured Cortical Neurons Induced by the Antiepileptic Drug Levetiracetam
View through CrossRef
Summary: Purpose:The present study explores the hypothesis that the antiepileptic mechanism of action of levetiracetam (LEV) is related to effects on α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor channels in mouse cortical neurons in culture.Methods:The neurons were subjected to the whole‐cell configuration of the patch‐clamp recording technique and were 8–12 days old in culture.Results:Kainate elicited concentration‐dependent (EC50= 80 μM) inward currents in all the patched cells. LEV (5–200 μM) itself did not induce inward or outward currents on all patched neurons, whereas it was effective on the kainate‐ and AMPA‐induced current because it significantly decreased the amplitude of these currents. LEV was also able to significantly decrease the total membrane conductance during kainate perfusion, indicating that its effect was not dependent on the cellular voltage membrane potential. Further evidence that LEV modulated the ionotropic non‐NMDA receptors came from the analysis of miniature excitatory postsynaptic currents (mEPSCs). In fact, LEV significantly decreased both the amplitude and the frequency of mEPSCs, as shown by the relative cumulative distributions.Conclusions:These results reveal that AMPA receptors are modulated by LEV because a significant decrease in the kainate‐ and AMPA‐induced currents and a decrease in amplitude and in frequency of mEPSCs have been observed in cortical neurons in culture. The described effect of LEV on AMPA receptors in cortical neurons is probably due to the etheromeric composition of the receptors and may be considered as a possible new antiepileptic mechanism of action.
Title: Modulation of AMPA Receptors in Cultured Cortical Neurons Induced by the Antiepileptic Drug Levetiracetam
Description:
Summary: Purpose:The present study explores the hypothesis that the antiepileptic mechanism of action of levetiracetam (LEV) is related to effects on α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor channels in mouse cortical neurons in culture.
Methods:The neurons were subjected to the whole‐cell configuration of the patch‐clamp recording technique and were 8–12 days old in culture.
Results:Kainate elicited concentration‐dependent (EC50= 80 μM) inward currents in all the patched cells.
LEV (5–200 μM) itself did not induce inward or outward currents on all patched neurons, whereas it was effective on the kainate‐ and AMPA‐induced current because it significantly decreased the amplitude of these currents.
LEV was also able to significantly decrease the total membrane conductance during kainate perfusion, indicating that its effect was not dependent on the cellular voltage membrane potential.
Further evidence that LEV modulated the ionotropic non‐NMDA receptors came from the analysis of miniature excitatory postsynaptic currents (mEPSCs).
In fact, LEV significantly decreased both the amplitude and the frequency of mEPSCs, as shown by the relative cumulative distributions.
Conclusions:These results reveal that AMPA receptors are modulated by LEV because a significant decrease in the kainate‐ and AMPA‐induced currents and a decrease in amplitude and in frequency of mEPSCs have been observed in cortical neurons in culture.
The described effect of LEV on AMPA receptors in cortical neurons is probably due to the etheromeric composition of the receptors and may be considered as a possible new antiepileptic mechanism of action.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Variable distributions of Ca(2+)-permeable and Ca(2+)-impermeable AMPA receptors on embryonic rat dorsal horn neurons
Variable distributions of Ca(2+)-permeable and Ca(2+)-impermeable AMPA receptors on embryonic rat dorsal horn neurons
1. By measuring the apparent reversal potential (aErev) of kainate- and alpha-amino-3-hydroxyl-5-methyl-4-isoxazole propionic acid (AMPA)-evoked currents associated with changes in...
Efficacy Of Phentoin Versus Levetiracetam In Children Presenting With Status Epilepticus At Tertiary Care Hospital Quetta
Efficacy Of Phentoin Versus Levetiracetam In Children Presenting With Status Epilepticus At Tertiary Care Hospital Quetta
Objectives: To assess and evaluate how well Phenytoin performs in treating status epilepticus as compared to Levetiracetam, in children at a tertiary care hospital in Quetta.
Study...
Levetiracetam-induced Rhabdomyolysis - A Rare Complication
Levetiracetam-induced Rhabdomyolysis - A Rare Complication
Background: Levetiracetam is an anti-epileptic drug that works by modulation of synaptic neurotransmitter release through binding to the synaptic vesicle protein 2A. Levetiracetam ...
Assessment of knowledge and practice of pediatric residents towards using and efficacy of levetiracetam as treatment for neonatal seizure
Assessment of knowledge and practice of pediatric residents towards using and efficacy of levetiracetam as treatment for neonatal seizure
Background: Seizures are a common neurologic complication in neonates, with severity ranging from mild to life-threatening. Despite their prevalence, clinical management guidelines...
BIT/SHPS‐1 Enhances Brain‐Derived Neurotrophic Factor‐Promoted Neuronal Survival in Cultured Cerebral Cortical Neurons
BIT/SHPS‐1 Enhances Brain‐Derived Neurotrophic Factor‐Promoted Neuronal Survival in Cultured Cerebral Cortical Neurons
Abstract: Brain‐derived neurotrophic factor (BDNF) activates a variety of signaling molecules to exert various functions in the nervous system, including neuronal differentiation, ...
A Suspected Case of Levetiracetam Induced Rhabdomyolysis
A Suspected Case of Levetiracetam Induced Rhabdomyolysis
Abstract
Background: Levetiracetam is a broad-spectrum antiseizure drug which works to terminate convulsions and is used in the treatment of certain types of seizures. It is common...
Efficacy and Safety of Using Levetiracetam and Phenobarbitone for the Treatment of Neonatal Seizure due to Hypoxic Ischemic Encephalopathy
Efficacy and Safety of Using Levetiracetam and Phenobarbitone for the Treatment of Neonatal Seizure due to Hypoxic Ischemic Encephalopathy
Background: Timely diagnosis and management of a patient of neonatal seizure are challenging due to limited resources and adverse effects produced by the drugs used. Phenobarbitone...

